Skip to main content

Table 3 Assessment of subject acceptability

From: Efficacy and safety of an antiviral Iota-Carrageenan nasal spray: a randomized, double-blind, placebo-controlled exploratory study in volunteers with early symptoms of the common cold

  ITT (n = 34) PP (n = 32) Subgroup (n = 11)
  Verum (n = 16) Placebo (n = 18) Verum (n = 14) Placebo (n = 18) Verum (n = 6) Placebo (n = 5)
Mean (SD) 6.63 (2.06) 5.39 (2.25) 7.07 (1.69) 5.39 (2.25) 7.50 (0.84) 4.20 (2.49)
p-Value 0.041 0.009 0.005
  1. Assessment of subject acceptability of Iota-Carrageenan vs. placebo nasal sprays in intention to treat (ITT), per protocol (PP) and subgroup (virus positive) analysis using a VAS scale (0- 10). P-values come from Mann-Whitney U-test. Unit: cm ± standard deviation.